scanX
Biocon
add_icon

Biocon

430.10
+11.10
(2.65%)
Market Cap
69,715.24 Cr
PE Ratio
183.84
Volume
81,77,038.00
Day High - Low
434.60 - 417.30
52W High-Low
424.95 - 327.60
ann
Company has added their latest Transcript1 day ago
Viewcross
right
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
69,715.24 Cr
EPS
2.82
PE Ratio
183.84
PB Ratio
2.00
Book Value
209.95
EBITDA
2,905.30
Dividend Yield
0.12 %
Industry
Healthcare
Sector
Pharmaceuticals
Return on Equity
5.16
Debt to Equity
0.84
Analyst Rating and Forecast
- By Refinitiv from15 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+53.33 %
+53.33 %
Hold
Hold+20.00 %
+20.00 %
Sell
Sell+26.67 %
+26.67 %
Forecast For
Actual

Company News

View All News
Caret
positive
Biocon Pharma Gets Health Canada Nod for Micafungin4 days ago
Biocon Pharma Limited, a subsidiary of Biocon Limited, receives Health Canada approval for Micafungin for Injection, USP, 50 mg and 100 mg, expanding its generics portfolio.
neutral
Biocon Q4FY26 Earnings Call Recording Now Available6 days ago
Biocon has made available the audio and video recording of its Q4 FY26 Earnings Call conducted on May 08, 2026, pursuant to Regulation 30 of SEBI LODR Regulations.
neutral
Biocon to Acquire ~2% Stake in Biocon Biologics7 days ago
Biocon approved acquiring ~2% stake in Biocon Biologics from employees/other shareholders via issuance of up to 87.9 lakh shares at ₹376.16 each, totalling ≈₹330.7 crore.
View more

Peer Comparison Compare Peers on Screener

Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
Sun Pharmaceutical
1,878.20
#1 4,50,643.09
40.81
#1 54,729.00
9.71
#1 10,980
16.07
64.89
Divis Laboratories
6,760.50
1,79,470.03
74.13
9,712.00
18.67
2,191
-1.02
64.06
Torrent Pharmaceuticals
4,405.70
1,49,108.91
65.68
11,539.40
6.99
1,911
26.24
58.52
Cipla
1,432.10
1,15,682.27
30.09
27,711.70
-2.46
3,783
-55.32
69.78
Dr Reddys Laboratories
1,336.70
1,11,566.73
26.16
33,593.30
-0.44
3,998
-86.05
59.87
Lupin
2,276.20
1,04,032.18
#1 19.28
27,487.50
19.98
5,345
#1 87.72
46.11
Mankind Pharma
2,503.00
1,03,325.11
56.36
12,744.20
20.90
2,007
7.65
73.37
Zydus Life Science
1,011.70
1,01,800.69
19.85
23,511.00
18.55
4,615
-0.32
69.47
Aurobindo Pharma
1,511.80
87,805.59
25.16
32,345.60
9.43
3,484
7.59
73.83
Laurus Labs
1,323.60
71,455.42
79.78
6,812.90
#1 21.03
884
21.18
80.26
Growth Rate
Revenue Growth
1.88 %
Net Income Growth
-99.70 %
Cash Flow Change
37.49 %
ROE
-
ROCE
-
EBITDA Margin (Avg.)
-36.11 %

Quarterly Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Revenue
952
778
800
811
1,223
1,029
989
1,086
974
986
1,025
1,098
1,242
1,193
1,564
1,585
1,557
1,483
1,673
1,784
1,621
1,712
1,765
1,885
2,060
1,808
1,945
2,223
2,476
2,217
2,384
3,020
3,929
3,516
3,551
4,135
3,912
4,543
3,604
3,826
4,415
3,990
4,356
4,240
4,537
Expenses
653
606
727
615
740
719
706
762
738
735
786
836
937
886
982
1,160
1,137
1,029
1,174
1,307
1,247
1,284
1,363
1,459
1,476
1,427
1,515
1,733
1,911
1,783
1,894
2,624
2,820
2,741
2,769
3,051
3,013
2,813
2,905
3,070
3,339
3,193
3,472
3,633
3,577
EBITDA
300
172
73
196
483
309
283
324
236
250
239
262
306
307
582
425
420
454
499
477
373
428
402
427
584
380
430
489
565
434
490
396
1,109
775
782
1,084
900
1,730
699
756
1,077
797
884
607
960
Operating Profit %
21 %
20 %
6 %
22 %
21 %
27 %
25 %
27 %
20 %
21 %
19 %
21 %
20 %
21 %
26 %
25 %
26 %
29 %
25 %
25 %
20 %
24 %
22 %
21 %
20 %
19 %
18 %
20 %
21 %
17 %
18 %
11 %
25 %
20 %
18 %
14 %
22 %
17 %
18 %
19 %
23 %
18 %
19 %
12 %
20 %
Depreciation
59
59
61
64
65
66
68
70
73
99
94
97
95
99
112
117
120
124
132
144
152
167
178
186
184
195
202
206
212
218
231
301
364
358
389
415
407
405
420
425
436
455
473
515
513
Interest
0
4
3
2
21
6
7
9
5
16
14
15
17
18
19
19
16
17
14
18
17
13
7
5
34
20
23
15
11
20
30
120
249
233
248
267
227
236
226
223
212
277
272
210
232
Profit Before Tax
249
165
20
141
409
238
208
245
159
135
132
150
193
190
451
289
284
313
354
315
204
249
218
236
366
166
206
269
343
197
229
-26
497
184
214
808
319
1,146
98
156
487
97
171
-68
248
Tax
32
34
18
19
55
55
42
54
10
38
43
36
41
52
73
46
41
85
100
85
45
81
22
49
69
57
46
49
59
30
147
-5
82
35
42
55
96
284
71
75
27
8
39
-16
49
Net Profit
217
131
2
122
354
182
167
191
148
98
89
114
153
138
378
243
243
228
254
230
159
168
195
187
296
108
160
220
284
167
82
-21
415
149
173
753
223
862
27
81
459
89
133
-52
199
EPS in ₹
10.08
6.31
-0.54
5.30
16.97
8.49
7.48
8.72
6.49
1.38
1.17
1.56
2.21
1.02
3.00
3.67
3.61
1.74
1.82
1.71
1.04
1.26
1.39
1.42
2.13
0.71
1.16
1.57
2.00
1.21
0.39
-0.35
2.62
0.85
1.05
5.52
1.13
5.51
-0.13
0.21
2.88
0.26
0.66
1.08
0.79
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Total Assets
6,375
8,458
9,394
9,990
12,192
14,444
18,522
20,394
52,043
0
58,797
63,651
Fixed Assets
1,630
1,749
3,626
3,700
4,471
5,971
6,364
6,569
29,468
0
31,963
25,095
Current Assets
2,563
3,971
4,048
4,149
4,889
5,325
7,600
8,382
12,334
0
16,286
17,180
Capital Work in Progress
1,677
2,240
839
1,303
1,899
2,196
2,800
4,110
7,317
0
8,508
4,613
Investments
230
901
1,253
675
1,012
966
1,952
1,588
2,069
0
1,127
6,086
Other Assets
2,839
3,569
3,676
4,312
4,811
5,311
7,406
8,127
13,189
0
17,199
0
Total Equity & Liabilities
6,375
8,458
9,394
9,990
12,192
14,444
18,522
20,394
52,043
0
58,797
63,651
Current Liabilities
1,555
1,666
1,678
2,141
3,039
4,008
4,210
3,828
8,511
0
14,334
14,069
Non Current Liabilities
1,378
2,493
2,502
2,200
2,447
3,053
5,805
7,096
21,043
0
16,751
12,960
Total Equity
3,443
4,300
5,214
5,649
6,707
7,383
8,508
9,470
22,489
0
27,713
34,032
Reserve & Surplus
3,171
3,992
4,738
4,881
5,798
6,106
7,027
7,832
17,267
0
21,044
33,221
Share Capital
100
100
100
300
300
600
600
600
600
0
600
811
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
-94
300
-47
-261
210
165
72
-243
641
-380
2,004
Investing Activities
-491
-1,138
-510
-684
-703
-1,505
-3,651
-1,662
-14,260
-1,002
-203
Operating Activities
211
371
640
662
1,155
1,283
1,160
1,177
1,853
2,954
4,061
Financing Activities
186
1,068
-178
-240
-242
388
2,564
242
13,049
-2,333
-1,854
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Jan 2026
Mar 2026
Promoter
60.67 %
60.64 %
60.64 %
60.64 %
60.64 %
60.64 %
60.64 %
60.64 %
60.64 %
60.64 %
60.64 %
60.64 %
60.64 %
60.64 %
60.64 %
60.64 %
60.64 %
54.45 %
54.45 %
54.45 %
44.91 %
44.91 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
7.96 %
6.55 %
5.63 %
5.90 %
5.93 %
5.66 %
5.66 %
6.04 %
6.61 %
7.39 %
7.14 %
7.52 %
DIIs
6.65 %
6.89 %
6.87 %
6.83 %
7.79 %
7.30 %
7.76 %
8.63 %
11.90 %
12.56 %
14.08 %
14.51 %
13.68 %
14.30 %
14.44 %
15.37 %
15.72 %
22.82 %
22.10 %
21.71 %
24.16 %
24.07 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
10.89 %
11.03 %
11.49 %
11.37 %
10.87 %
10.72 %
12.07 %
12.46 %
13.21 %
13.34 %
13.61 %
14.47 %
15.53 %
14.63 %
14.57 %
14.07 %
13.63 %
12.58 %
12.71 %
12.38 %
10.23 %
10.01 %
Others
21.79 %
21.44 %
21.00 %
21.16 %
20.70 %
21.35 %
19.54 %
18.27 %
14.26 %
13.46 %
3.70 %
3.83 %
4.52 %
4.53 %
4.42 %
4.27 %
4.34 %
4.10 %
4.12 %
4.06 %
13.55 %
13.49 %
No of Share Holders
0
3,11,349
3,38,815
3,63,447
3,64,502
3,47,911
3,41,016
3,69,816
4,11,086
4,12,441
4,15,046
4,34,339
4,70,261
4,43,513
4,39,503
4,27,705
4,24,297
4,30,217
4,13,191
3,94,279
3,94,215
3,86,593

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 3 1 1 0.00 0.00 0.5 1.5 0.5 0.5 0.00
Dividend Yield (%) 1.01 0.33 0.37 0.00 0.00 0.25 0.57 0.15 0.14 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
03 Jul 2026 DIVIDEND Dividend
₹ 0.50 /share
 03 Jul 2026 380.75 419.15
13 Jun 2019 BONUS Bonus
1:1
 12 Jun 2019 271.45 257.90
01 Jul 2022 DIVIDEND Dividend
₹ 0.50 /share
 30 Jun 2022 382.30 308.40
07 Jul 2023 DIVIDEND Dividend
₹ 1.50 /share
 07 Jul 2023 240.45 259.50
05 Jul 2024 DIVIDEND Dividend
₹ 0.50 /share
 05 Jul 2024 311.90 361.10
09 Aug 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
 09 Aug 2024 311.90 339.20
30 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 30 Oct 2024 370.65 326.85
30 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 30 Jan 2025 372.95 355.70
08 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 08 May 2025 339.10 346.50
04 Jul 2025 DIVIDEND Dividend
₹ 0.50 /share
 04 Jul 2025 346.50 374.40
07 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 07 Aug 2025 372.05 360.60
08 Aug 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
 08 Aug 2025 346.50 364.20
11 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 11 Nov 2025 352.25 382.15
31 Dec 2026 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
 31 Dec 2026 392.80 390.40
12 Feb 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 12 Feb 2026 371.80 375.80
07 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 07 May 2026 357.80 380.75

Announcements

Announcement under Regulation 30 (LODR)-Earnings Call Transcript1 day ago
Company Statement4 days ago
Announcement under Regulation 30 (LODR)-Newspaper Publication6 days ago
Announcement under Regulation 30 (LODR)-Newspaper Publication6 days ago
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot7 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome7 days ago
Announcement under Regulation 30 (LODR)-Investor Presentation7 days ago
Announcement under Regulation 30 (LODR)-Monitoring Agency Report8 days ago
Outcome Of Board Meeting_Change In Long Term Incentive Plan8 days ago
Announcement under Regulation 30 (LODR)-Issue of Securities8 days ago
Announcement under Regulation 30 (LODR)-Acquisition8 days ago
Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s8 days ago
Outcome Of Board Meeting_Completion Of Tenure Of Statutory Auditors8 days ago
Announcement under Regulation 30 (LODR)-Change in Directorate8 days ago
Announcement under Regulation 30 (LODR)-Change in Management8 days ago
Fixation Of Record Date For Dividend8 days ago
Corporate Action-Board approves Dividend8 days ago
Announcement under Regulation 30 (LODR)-Press Release / Media Release8 days ago
Board Meeting Outcome for Outcome Of Board Meeting8 days ago
Outcome Of Board Meeting-Financial Results8 days ago
Rumour Verification9 days ago
Rumour verification - Regulation 30(11)9 days ago
Clarification sought from Biocon Ltd9 days ago
Update on board meetingMay 04, 2026
Company StatementApr 30, 2026
Certificate Pursuant To SEBI Master Circular No. SEBI/HO/DDHS/DDHS-Pod/P/CIR/2025/0000000137 Dated October 15 2025Apr 29, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 28, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationApr 23, 2026
Board Meeting Intimation for Intimation Of The Board Meeting And Earnings Conference Call For Analysts And InvestorsApr 23, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 21, 2026
Reminder Letter To Shareholders Holding Shares In Physical Form For Furnishing Of KYC DetailsApr 20, 2026
Company StatementApr 08, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationApr 07, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 07, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 07, 2026
Intimation Of Change In Name Of Step-Down Subsidiary Of The CompanyMar 30, 2026
Amendment To Trust DeedMar 27, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMar 27, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementMar 27, 2026
Announcement under Regulation 30 (LODR)-Change in DirectorateMar 27, 2026
Board Meeting Outcome for Outcome Of Board MeetingMar 27, 2026
Closure of Trading WindowMar 26, 2026
Notification To Stock ExchangesMar 12, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 05, 2026
Announcement under Regulation 30 (LODR)-AcquisitionMar 03, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 02, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 25, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 24, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 17, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 17, 2026

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
ICICI Prudential Active Momentum Fund Direct-Growth
1.75%
931958
1.75%
1.75%
SBI Long Term Advantage Fund Series VI Direct-Growth
2.15%
150000
2.15%
2.15%
Helios Arbitrage Fund Direct-Growth
1.49%
20000
1.49%
1.49%
Old Bridge Arbitrage Fund Direct-Growth
0.23%
-5000
-0.16%
-0.63%
Tata Nifty Midcap 150 Index Fund Direct-Growth
0.66%
3983
-0.08%
-0.08%
Edelweiss Nifty LargeMidcap250 Plus 8-13 Yr G-Sec 70:30 Index Fund Direct-Growth
0.23%
2745
0.23%
0.23%
TRUSTMF Arbitrage Fund Direct-Growth
0.12%
2500
0.12%
0.12%
JioBlackRock Nifty Midcap 150 Index Fund Direct-Growth
0.66%
-1916
-0.09%
-0.08%
DSP Nifty Healthcare Index Fund Direct-Growth
2.54%
1079
-0.13%
-0.23%
Zerodha Nifty LargeMidcap250 Plus 8-13 Yr G-Sec 70:30 Index Fund Direct-Growth
0.23%
956
0.23%
0.23%
Kotak Nifty Midcap 150 Index Fund Direct-Growth
0.66%
813
-0.05%
-0.07%
Zerodha Nifty MidSmallcap400 50:50 Index Fund Direct-Growth
0.33%
721
0.33%
0.33%
DSP Nifty Midcap 150 Index Fund Direct-Growth
0.65%
251
-0.09%
-0.08%
Groww Nifty Midcap 150 Index Fund Direct-Growth
0.66%
95
-0.09%
-0.08%
Motilal Oswal BSE 1000 Index Fund Direct-Growth
0.13%
81
-0.01%
-0.01%
Navi Nifty MidSmallcap 400 Index Fund Direct-Growth
0.43%
54
-0.05%
-0.06%
DSP Nifty 500 Index Fund Direct-Growth
0.13%
40
-0.01%
-0.01%
Kotak Arbitrage Fund Direct-Growth
0.08%
0
0.00%
-0.03%
Mahindra Manulife Value Fund Direct-Growth
1.53%
0
0.00%
-0.25%
Axis Arbitrage Fund Direct-Growth
0.24%
0
0.00%
-0.06%
Axis Balanced Advantage Fund Direct-Growth
0.01%
0
0.00%
0.00%
Axis Business Cycles Fund Direct-Growth
0.00%
0
0.00%
0.00%
Axis Equity Savings Fund Direct-Growth
0.04%
0
0.00%
0.00%
Axis Flexi Cap Fund Direct-Growth
0.00%
0
0.00%
0.00%
Axis India Manufacturing Fund Direct-Growth
0.00%
0
0.00%
0.00%

Technical Indicators

RSI(14)
Neutral
77.19
ATR(14)
Less Volatile
11.98
STOCH(9,6)
Overbought
86.68
STOCH RSI(14)
Overbought
100.00
MACD(12,26)
Bullish
6.76
ADX(14)
Strong Trend
26.71
UO(9)
Bearish
59.53
ROC(12)
Uptrend But Slowing Down
15.75
WillR(14)
Overbought
-7.11
Bearish
5
Neutral
2
Bullish
2

About Biocon

Biocon Limited is India's largest fully-integrated biopharmaceutical company, focusing on biotechnology products and research services. Founded in 1978, Biocon specializes in treating diabetes, cancer, and autoimmune diseases. The company develops and commercializes novel biologics, biosimilars, complex small molecule APIs, and generic formulations for global markets. Biocon's product portfolio includes cardiology,...more
Listing Date
07 Apr, 2004(22 Years, 9 days)
Website
https://www.biocon.com
Chairperson NameKiran Mazumdar Shaw
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Fundamental Screeners
Technical Screeners
Intraday Screeners
Price & Volume Screeners
Candlestick Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
Sensex Companies
Nifty 50 Companies
Nifty Next 50 Companies
Nifty Bank Companies
Finnifty Companies
Defence Stocks
Semi Conductor Stocks
Renewable Energy Stocks
AI Stocks
Cement Stocks
Penny Stocks
Multibagger Stocks
Breakout Stocks
Dividend Stocks
Large Cap Stocks
Mid Cap Stocks
Small Cap Stocks
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.
We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.
This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.
The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.
We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.
This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.
By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.
We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.

© 2025 - 2026 Raise Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Registered Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai - 400104